These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7499115)

  • 21. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
    Loprinzi CL; Kuross SA; O'Fallon JR; Gesme DH; Gerstner JB; Rospond RM; Cobau CD; Goldberg RM
    J Clin Oncol; 1994 Jun; 12(6):1121-5. PubMed ID: 8201373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)].
    Quattrin N; Montuori R
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):178-9. PubMed ID: 4968995
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of clinical study antitumor action of hydrazine sulfate.
    Gershanovich ML; Danova LA; Ivin BA; Filov VA
    Nutr Cancer; 1981; 3(1):7-12. PubMed ID: 7050922
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease].
    Hollard D; Schaerrer R
    Lyon Med; 1966 Apr; 215(17):1167-74. PubMed ID: 5930371
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in the pharmacology of cancer chemotherapy.
    Smith SD
    Pediatr Clin North Am; 1981 Feb; 28(1):145-60. PubMed ID: 6259577
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    Zarrilli D; Perrone V; Pergola M
    Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
    [No Abstract]   [Full Text] [Related]  

  • 32. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer.
    Loprinzi CL; Goldberg RM; Su JQ; Mailliard JA; Kuross SA; Maksymiuk AW; Kugler JW; Jett JR; Ghosh C; Pfeifle DM
    J Clin Oncol; 1994 Jun; 12(6):1126-9. PubMed ID: 8201374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 34. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.
    Kosty MP; Fleishman SB; Herndon JE; Coughlin K; Kornblith AB; Scalzo A; Morris JC; Mortimer J; Green MR
    J Clin Oncol; 1994 Jun; 12(6):1113-20. PubMed ID: 8201372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma].
    Fazio M; Cavallero P; Sartoris S; Vergnano F; Pegoraro L
    Minerva Med; 1965 Dec; 56(99):4338-43. PubMed ID: 5323491
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytostatic therapy of malignant lymphoma].
    Kühböck J
    Wien Klin Wochenschr; 1971 Jul; 83(27):516-22. PubMed ID: 5123478
    [No Abstract]   [Full Text] [Related]  

  • 38. Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.
    Gold J
    Nutr Cancer; 1981; 3(1):13-9. PubMed ID: 7050921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
    Schöffski P; Sufliarsky J; Gelderblom H; Blay JY; Strauss SJ; Stacchiotti S; Rutkowski P; Lindner LH; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Nzokirantevye A; Collette S; Wozniak A
    Lancet Respir Med; 2018 Jun; 6(6):431-441. PubMed ID: 29669701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.